Fonte: Investigational New Drugs. Unidade: FM
Assuntos: ESTRESSE, NEOPLASIAS (TERAPIA), MECANISMOS DE CONTROLE CELULAR, ADENOCARCINOMA, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIA, Durvanei Augusto et al. A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production. Investigational New Drugs, v. 31, n. 3, p. 493-505, 2013Tradução . . Disponível em: http://link.springer.com/article/10.1007/s10637-012-9871-1. Acesso em: 31 ago. 2024.APA
Maria, D. A., Souza, J. G. de, Morais, K. L. P., Berra, C. M., Zampolli, H. de C., Demasi, M., et al. (2013). A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production. Investigational New Drugs, 31( 3), 493-505. doi:10.1007/s10637-012-9871-1NLM
Maria DA, Souza JG de, Morais KLP, Berra CM, Zampolli H de C, Demasi M, Simons SM, Saito R de F, Chammas R, Chudzinski-Tavassi AM. A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production [Internet]. Investigational New Drugs. 2013 ; 31( 3): 493-505.[citado 2024 ago. 31 ] Available from: http://link.springer.com/article/10.1007/s10637-012-9871-1Vancouver
Maria DA, Souza JG de, Morais KLP, Berra CM, Zampolli H de C, Demasi M, Simons SM, Saito R de F, Chammas R, Chudzinski-Tavassi AM. A novel proteasome inhibitor acting in mitochondrial dysfunction, ER stress and ROS production [Internet]. Investigational New Drugs. 2013 ; 31( 3): 493-505.[citado 2024 ago. 31 ] Available from: http://link.springer.com/article/10.1007/s10637-012-9871-1